As an advanced cancer patient who also works for one of the most innovative tech companies on the planet, Bryce lives on the edge of a space that is equal parts exhilaration and exhaustion. The exhilaration comes from his exposure to potentially life-saving biomedical insights being discovered in the industry. The exhaustion comes from trying to get adoption for these new biomedical insights to affect his and other advanced cancer patients' care. By the time medical professionals have conversations with patients about these capabilities, it's often too late. It's why he started SequenceMe.org.
Today at the HLTH conference in Vegas he announced a new collaboration with Clear Genetics (cleargenetics.com), a software company building technology, including an AI-driven platform, to scale the delivery of genetic and genomic services.
Read Full Story at Intel: intel.ai/sequenceme-hlth
Disclaimer: This post is shared for educational purposes only and is not medical advice. It does not replace the guidance of your healthcare team. Always consult your own doctors about your specific care.